Učitavanje...
Effect of Body Mass Index (BMI) on Tumor Characteristics and Disease-Free Survival in Patients from the HER2-Positive Adjuvant Trastuzumab Trial N9831
BACKGROUND: Data suggest that weight, and specifically BMI, plays a role in breast cancer development and outcome. We hypothesized there would be a correlation between BMI and clinical outcome in patients with early stage HER2-positive breast cancer enrolled in the N9831 adjuvant trial. METHODS: Pat...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3686994/ https://ncbi.nlm.nih.gov/pubmed/23585192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28051 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|